Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients
2000 ◽
Vol 106
(1)
◽
pp. 101-109
◽
Keyword(s):
Bet V 1
◽
2009 ◽
Vol 124
(1)
◽
pp. 135-142.e21
◽